Mar 14, 2013 ... Bristol-Myers Squibb Co. and partner Sanofi-Aventis SA won a defense verdict
Wednesday in a $3.4 billion ... The case is Apotex Inc. et al. v.
Nov 20, 2013 ... Regarding the optimal dose and schedule of administration (2 vs. ..... to the minor
groove of DNA and induces DNA double-strand breaks. ..... Conflicts of interest:
EMO: Consultancy: Onyx; Bristol Myers Squibb; Array Pharmaceuticals. .... Siegel
DS, Martin T, Wang M, Vij R, Jakubowiak AJ, Lonial S, et al.
BMS-488043 is compound 5ao in a patent by T. Wang et al. ... from the University
of Massachusetts or were prepared at Bristol-Myers Squibb Company. .....
Inhibition of virion (WT versus ΔCT)-sCD4 binding by attachment inhibitors ...
CD4-induced exposure of the virion N-terminal heptad repeat groove was probed
by C34 ...
Apr 3, 2014 ... Bristol-Myers Squibb Company v. Apotex Inc. et al. 1:14-cv-00351; filed March 19
, 2014 in the District Court of Delaware • Plaintiff: Bristol-Myers ...
Apr 17, 2002 ... Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb
Pharmaceutical Research Institute, Pennington, ... 1993; Grover et al., 1995a;
Chutkow et al., 1996; Inagaki et ... openers such as BMS-180448 and BMS-
191095 (Atwal et al., ...... APD shortening effects versus cardioprotection (Atwal et
Jun 21, 2016 ... One is nivolumab or Opdivo from Bristol-Myers Squibb. ... that the C′D loop of
hPD-1 protrudes into a groove formed by the CDRs and FR of pembrolizumab
Fab. .... Article | PubMed |; Cheng X, Veverka V, Radhakrishnan A, et al. ... 07
August 2016 — 12 August 2016; 110 Carriage Way, CO, United States.
www.navigant.com/~/media/WWW/Site/Insights/Disputes Investigations/FCA_Quarterly Report Tracker for pdf_Sept 2013.pdf
Jun 28, 2013 ... Crawley V. Harrisburg Area Community College Et Al. Todd A. Crawley. Frank P.
...... Robert A. Grover, DO; Robert. A. Grover, DO, PA .... United States Of America
Et Al V. Bristol Myers Squibb Company Et Al. United States of ...
Louis Rosenfeld,1 Gary J. Grover,2 and Charles T. Stier, Jr.1. 1Department of ...
2Division of Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb,
.... From the analogs prepared, BMS-180,291: [(+)-1S-(1a,2a,3a, ... scopic
analysis was developed by Jemal et al. ..... by combination with aspirin (12 ± 2 vs.
From the Department of Pharmacology, Bristol-Myers Squibb. Pharmaceutical ...
Grover et al KATP and Al-Receptors in Preconditioning. 1311 artery for ... min
glyburide (Sigma Chemical Co., St. Louis, Mo.) .... V * 51.94 3.61x R . 0.30 a cc u.
113 Results ... Rat heart mitochondria were prepared according to Matlib et al<sup>17</sup> and inner ....
was synthesized in the Department of Chemistry at Bristol-Myers Squibb. All
other compounds were obtained from Sigma Chemical Co. ..... Relative K<sup>+</sup> flux, (
ΔJ/ΔJmax) is plotted vs concentration of drug added to the assay.